(Press-News.org) Researchers at Karolinska Institutet have found a molecule that can both help the intestines to heal after damage and suppress tumour growth in colorectal cancer. The discovery could lead to new treatments for inflammatory bowel disease (IBD) and cancer. The results are published in the journal Nature.
Many patients with inflammatory bowel disease (IBD) such as Crohn’s disease or ulcerative colitis do not respond to available treatments, highlighting the need to identify novel therapeutic strategies. In a new study published in Nature, researchers propose that promoting mucosal healing through tissue regeneration could be a valid alternative to immunosuppressive drugs.
“However, it’s virtually impossible to promote tissue regeneration without the risk of inducing tumour growth, as cancer cells can hijack the body’s natural healing processes and start to grow uncontrollably,” says lead author Srustidhar Das, research specialist in Eduardo Villablanca’s research group at Karolinska Institutet’s Department of Medicine in Solna. “We’ve now identified a molecule that can help the intestines to heal after damage while suppressing tumour growth in colorectal cancer.”
In their search for new ways to treat IBD, the researchers have identified a handful of molecules with drug-candidate potential. They found that activation of a protein called the Liver X receptor (LXR) can promote regeneration and suppress tumour growth in colorectal cancer.
“The discovery of both these functions was astonishing,” says last author Eduardo J. Villablanca, Docent at Karolinska Institutet. “We now need to study how LXR controls tumour formation more closely.”
The researchers used a collection of advanced technologies to conduct their study, which included mapping the transcriptome of intestinal cells. The researchers also cultivated what are known as 3D organoids: small, three-dimensional cell structures that mimic the function and structure of the body’s own organs, albeit in miniature format. They then used spatial transcriptomics to map the gene expression in the different tissues, a technique that has been developed at SciLifeLab by scientists from the Royal Institute of Technology (KTH) and Karolinska Institutet in Sweden.
Every year, over 7,000 people in Sweden develop bowel or rectal cancer, making it the third most common form of cancer in Sweden. Patients are often treated with chemotherapy and radiotherapy, but this can cause irritation and swelling of the bowel mucosa with subsequent chronic intestinal inflammation.
“Thus, this new therapeutic molecule has the potential to treat not only IBD patients but also cancer patients to prevent chronic bowel disorders after radiotherapy and/or chemotherapy,” says Eduardo J. Villablanca.
The study was conducted with grants from several bodies, including the Swedish Research Council, Formas (The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning), the Silicon Valley Community Foundation, Novo Nordisk, the Swedish Cancer Society, the Knut and Alice Wallenberg Foundation and the Åke Wiberg Foundation.
Two of the authors have reported potential conflicts of interest: Eduardo J. Villablanca has received research funding from the pharmaceutical company F. Hoffmann-La Roche and Srustidhar Das works as a consultant for Cellphi Biotechnology AB.
Publication: “Liver X receptor unlinks intestinal regeneration and tumorigenesis”, Srustidhar Das, S. Martina. Parigi, Xinxin Luo, Jennifer Fransson, Bianca Carola Kern, Ali Okhovat, Oscar E. Diaz, Chiara Sorini, Paulo Czarnewski, Anna T. Webb, Rodrigo A. Morales, Sacha Lebon, Gustavo Monasterio, Francisca Castillo, Kumar P. Tripathi, Ning He, Penelope Pelczar, Nicola Schaltenberg, Marjorie De la Fuente, Francisco López-Köstner, Susanne Nylén, Hjalte List Larsen, Raoul Kuiper, Per Antonson, Marcela A. Hermoso, Samuel Huber, Moshe Biton, Sandra Scharaw, Jan-Åke Gustafsson, Pekka Katajisto, Eduardo J. Villablanca, Nature, online 20 November 2024, doi: 10.1038/s41586-024-08247-6.
END
First molecule identified that promotes gut healing while inhibiting tumour progression
2024-11-20
ELSE PRESS RELEASES FROM THIS DATE:
Trends in postpartum depression by race, ethnicity, and prepregnancy BMI
2024-11-20
About The Study: In this cross-sectional study, postpartum depression (PPD) diagnosis increased significantly across all racial and ethnic groups and body mass index (BMI) categories over the past decade. While rising PPD may reflect improved screening and diagnosis practices, the persistently high rates highlight the need to develop and implement interventions to prevent the condition while expanding efforts to mitigate the impact of PPD on maternal and child health.
Corresponding Author: To contact the corresponding author, Darios Getahun, MD, PhD, ...
Short-term and long-term mortality risk after preterm birth
2024-11-20
About The Study: The findings of this population-based matched cohort study suggest that individuals born preterm were at an increased risk of death from birth until their third and fourth decades of life, with higher risks as gestational age decreased. Some of these associations may have been partly due to underlying health determinants that affected preterm birth and mortality. These findings suggest that preterm birth should be recognized as a risk factor for mortality and could inform preventive strategies.
Corresponding Author: To contact the corresponding author, Asma M. Ahmed, PhD, MD, MPH, email asahmed@wakehealth.edu.
To access ...
Thanksgiving special: dinosaur drumsticks and the story of the turkey trot
2024-11-20
New Haven, Conn. — Wings may be the obvious choice when studying the connection between dinosaurs and birds, but a pair of Yale paleontologists prefer drumsticks. That part of the leg, they say, is where fibular reduction among some dinosaurs tens of millions of years ago helped make it possible for peacocks to strut, penguins to waddle, and turkeys to trot.
“A good way to understand this is to take a look at drumsticks, like the ones people eat on Thanksgiving,” said Armita Manafzadeh, lead author ...
Superior photosynthesis abilities of some plants could hold key to climate-resilient crops
2024-11-20
LA JOLLA (November 20, 2024)—More than 3 billion years ago, on an Earth entirely covered with water, photosynthesis first evolved in little ancient bacteria. In the following many millions of years, those bacteria evolved into plants, optimizing themselves along the way for various environmental changes. This evolution was punctuated around 30 million years ago with the emergence of a newer, better way to photosynthesize. While plants like rice continued using an old form of photosynthesis known as C3, others like corn and sorghum developed a newer and more efficient version called C4.
There are now more than 8,000 different C4 plant ...
Human immune system is ‘ready to go’ long before birth
2024-11-20
By creating the first spatial atlas of the developing human thymus, a vital organ that trains immune cells to protect against infections and cancer, scientists have discovered that the foundation for lifelong immunity is established earlier than previously thought.
Researchers from the Wellcome Sanger Institute and their collaborators at Ghent University, Belgium, the National Institutes of Health’s National Institute of Allergy and Infectious Diseases and others, uncovered key differences in the development of immune cells. This understanding could help scientists ...
R sounds are rough, and L sounds are smooth, according to cross-cultural study
2024-11-20
University of Birmingham Press Release
STRICTLY EMBARGOED UNTIL: 16.00pm Wednesday 20th November UK time/11.00am Wednesday 20th November EST.
R sounds are rough, and L sounds are smooth, according to cross-cultural study
People around the world associate a trilled R sound with a rough texture and a jagged shape, and an L sound with smooth texture and a flat shape, according to the findings of a new study. Researchers believe this association may be more universal than the famous bouba/kiki effect.
New research from the University of Birmingham (UK), ...
Healthy women have cells that resemble breast cancer, study finds
2024-11-20
HOUSTON ― A new study from researchers at The University of Texas MD Anderson Cancer Center finds that, in healthy women, some breast cells that otherwise appear normal may contain chromosome abnormalities typically associated with invasive breast cancer. The findings question conventional thinking on the genetic origins of breast cancer, which could influence early cancer detection methods.
The study, published today in Nature, discovered that at least 3% of normal cells from breast tissue in ...
Cancer-like mutations in healthy cells point to origins of breast cancer
2024-11-20
Researchers at the University of British Columbia (UBC), BC Cancer, Harvard Medical School and Memorial Sloan Kettering Cancer Center (MSK) have pinpointed what could be the early genetic origins of breast cancer—cancer-like mutations appearing in the cells of healthy women.
In a new study, the international collaborators analyzed the genomes of more than 48,000 individual breast cells from women without cancer, using novel techniques for decoding the genes of single cells. While the vast majority of cells appeared normal, nearly all of the women harboured a small number of breast cells—about 3 per cent—that carried ...
Preterm birth associated with increased mortality risk into adulthood, study finds
2024-11-20
WINSTON-SALEM, N.C. – Nov. 20, 2024 – According to a new study from researchers at Wake Forest University School of Medicine and The Hospital for Sick Children (SickKids) in Toronto, being born preterm is associated with an increased risk of death from birth until the third and fourth decades of life.
The study appears online today in JAMA Network Open.
About 10% of all births worldwide are classified as preterm, which occurs when a baby is born before 37 weeks gestation. Globally, preterm birth is the leading cause of infant mortality and the second leading cause of death for children under the age of 5.
“Understanding the long-term effects of preterm birth ...
Genome Research publishes a Special Issue on Long-read DNA and RNA Sequencing Applications in Biology and Medicine
2024-11-20
Genome Research publishes a Special Issue on Long-read DNA and RNA Sequencing Applications in Biology and Medicine
November 20, 2024 – Genome Research (https://genome.org) publishes a special issue highlighting advances in long-read sequencing applications in biology and medicine.
In this first of two Special Issues guest-edited by Dr. Ana Conesa, Dr. Alexander Hoischen, and Dr. Fritz Sedlazeck, Genome Research publishes a diverse collection of research and review articles highlighting novel applications and developments in long-read sequencing (LRS). Papers in this issue focus on original research offering novel biological and clinical ...